Chlamydia pneumoniae entry into epithelial cells by clathrin-independent endocytosis

Microbial Pathogenesis

Volumn 52, Issue 3, 2012, Pages 157-164

  Korhonen, Juha T ^a,b,c   Puolakkainen, Mirja ^d,e   Haveri, Anu ^e   Tammiruusu, Anne ^e   Sarvas, Matti ^e   Lahesmaa, Riitta ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c Drug Discovery Graduate School   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Chlamydia pneumoniae; Clathrin; Lipid rafts; SR BI

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE; CLATHRIN; FILIPIN; NYSTATIN; SPHINGOMYELIN; TOLL LIKE RECEPTOR 4;

ARTICLE; BACTERIAL GROWTH; CELL INTERACTION; CELL INVASION; CELL MEMBRANE; CENTRIFUGATION; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; EPITHELIUM CELL; HOST CELL; HUMAN; HUMAN CELL; INTERNALIZATION; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RNA INTERFERENCE; SCINTILLATION; TERATOLOGY;

BACTERIAL ADHESION; CELL LINE; CELL MEMBRANE; CHLAMYDOPHILA PNEUMONIAE; CLATHRIN; ENDOCYTOSIS; EPITHELIAL CELLS; GENE SILENCING; HUMANS; MEMBRANE MICRODOMAINS; RNA INTERFERENCE; SCAVENGER RECEPTORS, CLASS B;

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; NEGIBACTERIA;

EID: 84856237323     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.12.002     Document Type: Article

References (73)

1. Kuo C.C., Jackson L.A., Campbell L.A., Grayston J.T. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995, 8:451-461.
2. Campbell L.A., Kuo C.C. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis?. Nat Rev Microbiol 2004, 2:23-32.
3. Wyrick P.B. Intracellular survival by Chlamydia. Cell Microbiol 2000, 2:275-282.
4. Fields K.A., Hackstadt T. The chlamydial inclusion: escape from the endocytic pathway. Annu Rev Cell Dev Biol 2002, 18:221-245.
5. Cocchiaro J.L., Valdivia R.H. New insights into Chlamydia intracellular survival mechanisms. Cell Microbiol 2009, 11:1571-1578.
6. Dautry-Varsat A., Subtil A., Hackstadt T. Recent insights into the mechanisms of Chlamydia entry. Cell Microbiol 2005, 7:1714-1722.
7. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
8. Simons K., Ikonen E. How cells handle cholesterol. Science 2000, 290:1721-1726.
9. Anderson R.G. The caveolae membrane system. Annu Rev Biochem 1998, 67:199-225.
10. Duncan M.J., Shin J.S., Abraham S.N. Microbial entry through caveolae: variations on a theme. Cell Microbiol 2002, 4:783-791.
11. Lafont F., van der Goot F.G. Bacterial invasion via lipid rafts. Cell Microbiol 2005, 7:613-620.
12. Manes S., del Real G., Martinez-A C. Pathogens: raft hijackers. Nat Rev Immunol 2003, 3:557-568.
13. Shin J.S., Abraham S.N. Caveolae as portals of entry for microbes. Microbes Infect 2001, 3:755-761.
14. Zaas D.W., Duncan M., Rae Wright J., Abraham S.N. The role of lipid rafts in the pathogenesis of bacterial infections. Biochim Biophys Acta 2005, 1746:305-313.
15. Shin J.S., Abraham S.N. Co-option of endocytic functions of cellular caveolae by pathogens. Immunology 2001, 102:2-7.
16. Vieira F.S., Correa G., Einicker-Lamas M., Coutinho-Silva R. Host-cell lipid rafts: a safe door for micro-organisms?. Biol Cell 2010, 102:391-407.
17. Jutras I., Abrami L., Dautry-Varsat A. Entry of the lymphogranuloma venereum strain of Chlamydia trachomatis into host cells involves cholesterol-rich membrane domains. Infect Immun 2003, 71:260-266.
18. Norkin L.C., Wolfrom S.A., Stuart E.S. Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection. Exp Cell Res 2001, 266:229-238.
19. Stuart E.S., Webley W.C., Norkin L.C. Lipid rafts, caveolae, caveolin-1, and entry by Chlamydiae into host cells. Exp Cell Res 2003, 287:67-78.
20. Gabel B.R., Elwell C., van Ijzendoorn S.C., Engel J.N. Lipid raft-mediated entry is not required for Chlamydia trachomatis infection of cultured epithelial cells. Infect Immun 2004, 72:7367-7373.
21. Hybiske K., Stephens R.S. Entry mechanisms of Chlamydia trachomatis into non-phagocytic cells. Infect Immun 2007.
22. Vishnyakova T.G., Kurlander R., Bocharov A.V., Baranova I.N., Chen Z., Abu-Asab M.S., et al. CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells. Proc Natl Acad Sci USA 2006, 103:16888-16893.
23. Christian A.E., Haynes M.P., Phillips M.C., Rothblat G.H. Use of cyclodextrins for manipulating cellular cholesterol content. JLipid Res 1997, 38:2264-2272.
24. Sharma D.K., Brown J.C., Choudhury A., Peterson T.E., Holicky E., Marks D.L., et al. Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol Biol Cell 2004, 15:3114-3122.
25. Wuppermann F.N., Hegemann J.H., Jantos C.A. Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae. JInfect Dis 2001, 184:181-187.
26. Chen J.C., Stephens R.S. Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells. Mol Microbiol 1994, 11:501-507.
27. Gupta V.R., Patel H.K., Kostolansky S.S., Ballivian R.A., Eichberg J., Blanke S.R. Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLoS Pathog 2008, 4:e1000073.
28. Saslowsky D.E., Lencer W.I. Conversion of apical plasma membrane sphingomyelin to ceramide attenuates the intoxication of host cells by cholera toxin. Cell Microbiol 2008, 10:67-80.
29. McGookey D.J., Fagerberg K., Anderson R.G. Filipin-cholesterol complexes form in uncoated vesicle membrane derived from coated vesicles during receptor-mediated endocytosis of low density lipoprotein. JCell Biol 1983, 96:1273-1278.
30. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., Anderson R.G. Caveolin, a protein component of caveolae membrane coats. Cell 1992, 68:673-682.
31. Marsh M., Helenius A. Virus entry: open sesame. Cell 2006, 124:729-740.
32. Veiga E., Cossart P. The role of clathrin-dependent endocytosis in bacterial internalization. Trends Cell Biol 2006, 16:499-504.
33. Hodinka R.L., Wyrick P.B. Ultrastructural study of mode of entry of Chlamydia psittaci into L-929 cells. Infect Immun 1986, 54:855-863.
34. Wyrick P.B., Choong J., Davis C.H., Knight S.T., Royal M.O., Maslow A.S., et al. Entry of genital Chlamydia trachomatis into polarized human epithelial cells. Infect Immun 1989, 57:2378-2389.
35. Motley A., Bright N.A., Seaman M.N., Robinson M.S. Clathrin-mediated endocytosis in AP-2-depleted cells. JCell Biol 2003, 162:909-918.
36. Foster K.A., Oster C.G., Mayer M.M., Avery M.L., Audus K.L. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res 1998, 243:359-366.
37. Rupp J., Droemann D., Goldmann T., Zabel P., Solbach W., Vollmer E., et al. Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection. FEMS Immunol Med Microbiol 2004, 41:197-203.
38. Calvo D., Vega M.A. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. JBiol Chem 1993, 268:18929-18935.
39. Babitt J., Trigatti B., Rigotti A., Smart E.J., Anderson R.G., Xu S., et al. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. JBiol Chem 1997, 272:13242-13249.
40. Rhainds D., Bourgeois P., Bourret G., Huard K., Falstrault L., Brissette L. Localization and regulation of SR-BI in membrane rafts of HepG2 cells. JCell Sci 2004, 117:3095-3105.
41. Zaretzky F.R., Pearce-Pratt R., Phillips D.M. Sulfated polyanions block Chlamydia trachomatis infection of cervix-derived human epithelia. Infect Immun 1995, 63:3520-3526.
42. Lavillette D., Tarr A.W., Voisset C., Donot P., Bartosch B., Bain C., et al. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 2005, 41:265-274.
43. Voisset C., Callens N., Blanchard E., Op De Beeck A., Dubuisson J., Vu-Dac N. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. JBiol Chem 2005, 280:7793-7799.
44. Majeed M., Kihlstrom E. Mobilization of F-actin and clathrin during redistribution of Chlamydia trachomatis to an intracellular site in eucaryotic cells. Infect Immun 1991, 59:4465-4472.
45. Reynolds D.J., Pearce J.H. Characterization of the cytochalasin D-resistant (pinocytic) mechanisms of endocytosis utilized by chlamydiae. Infect Immun 1990, 58:3208-3216.
46. Boleti H., Benmerah A., Ojcius D.M., Cerf-Bensussan N., Dautry-Varsat A. Chlamydia infection of epithelial cells expressing dynamin and Eps15 mutants: clathrin-independent entry into cells and dynamin-dependent productive growth. JCell Sci 1999, 112(Pt 10):1487-1496.
47. Pizarro-Cerda J., Bonazzi M., Cossart P. Clathrin-mediated endocytosis: what works for small, also works for big. Bioessays 2010, 32:496-504.
48. Kuo C.C., Chi E.Y., Grayston J.T. Ultrastructural study of entry of Chlamydia strain TWAR into HeLa cells. Infect Immun 1988, 56:1668-1672.
49. Dreja K., Voldstedlund M., Vinten J., Tranum-Jensen J., Hellstrand P., Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler Thromb Vasc Biol 2002, 22:1267-1272.
50. Hailstones D., Sleer L.S., Parton R.G., Stanley K.K. Regulation of caveolin and caveolae by cholesterol in MDCK cells. JLipid Res 1998, 39:369-379.
51. Rodal S.K., Skretting G., Garred O., Vilhardt F., van Deurs B., Sandvig K. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell 1999, 10:961-974.
52. Grimmer S., van Deurs B., Sandvig K. Membrane ruffling and macropinocytosis in A431 cells require cholesterol. JCell Sci 2002, 115:2953-2962.
53. Cheng Z.J., Singh R.D., Sharma D.K., Holicky E.L., Hanada K., Marks D.L., et al. Distinct mechanisms of clathrin-independent endocytosis have unique sphingolipid requirements. Mol Biol Cell 2006, 17:3197-3210.
54. Subtil A., Wyplosz B., Balana M.E., Dautry-Varsat A. Analysis of Chlamydia caviae entry sites and involvement of Cdc42 and Rac activity. JCell Sci 2004, 117:3923-3933.
55. Slotte J.P., Bierman E.L. Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem J 1988, 250:653-658.
56. Krivan H.C., Nilsson B., Lingwood C.A., Ryu H. Chlamydia trachomatis and Chlamydia pneumoniae bind specifically to phosphatidylethanolamine in HeLa cells and to GalNAc beta 1-4Gal beta 1-4GLC sequences-found in asialo-GM1 and asial-GM2. Biochem Biophys Res Commun 1991, 175:1082-1089.
57. Krivan H.C., Roberts D.D., Ginsburg V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci USA 1988, 85:6157-6161.
58. Soong G., Reddy B., Sokol S., Adamo R., Prince A. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. JClin Invest 2004, 113:1482-1489.
59. Philips J.A., Rubin E.J., Perrimon N. Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 2005, 309:1251-1253.
60. Rodrigues C.D., Hannus M., Prudencio M., Martin C., Goncalves L.A., Portugal S., et al. Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host Microbe 2008, 4:271-282.
61. Barth H., Schnober E.K., Neumann-Haefelin C., Thumann C., Zeisel M.B., Diepolder H.M., et al. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. JVirol 2008, 82:3466-3479.
62. Bartosch B., Vitelli A., Granier C., Goujon C., Dubuisson J., Pascale S., et al. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. JBiol Chem 2003, 278:41624-41630.
63. Guo L., Song Z., Li M., Wu Q., Wang D., Feng H., et al. Scavenger receptor BI protects against septic death through its role in modulating inflammatory response. JBiol Chem 2009, 284:19826-19834.
64. Li X.A., Guo L., Asmis R., Nikolova-Karakashian M., Smart E.J. Scavenger receptor BI prevents nitric oxide-induced cytotoxicity and endotoxin-induced death. Circ Res 2006, 98:e60-e65.
65. Cles L.D., Stamm W.E. Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. JClin Microbiol 1990, 28:938-940.
66. Kuo C.C., Grayston J.T. Asensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. JInfect Dis 1990, 162:755-758.
67. Ekman M.R., Grayston J.T., Visakorpi R., Kleemola M., Kuo C.C., Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993, 17:420-425.
68. Caldwell H.D., Kromhout J., Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981, 31:1161-1176.
69. Melgosa M.P., Kuo C.C., Campbell L.A. Outer membrane complex proteins of Chlamydia pneumoniae. FEMS Microbiol Lett 1993, 112:199-204.
70. Byrne G.I. Kinetics of phagocytosis of Chlamydia psittaci by mouse fibroblasts (L cells): separation of the attachment and ingestion stages. Infect Immun 1978, 19:607-612.
71. Mori S., Tanaka M., Nanba D., Nishiwaki E., Ishiguro H., Higashiyama S., et al. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. JBiol Chem 2003, 278:46029-46034.
72. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
73. Mannonen L., Kamping E., Penttila T., Puolakkainen M. IFN-gamma induced persistent Chlamydia pneumoniae infection in HL and mono Mac 6 cells: characterization by real-time quantitative PCR and culture. Microb Pathog 2004, 36:41-50.